Colorless liquid with a slightly sharp odor. [Note: The pure compound is a crystalline solid below 12°F. Often used in an aqueous solution.]
颜色/状态:
Colorless liquid
气味:
... Slightly sharp odor ...
味道:
Bitter
溶解度:
In water, 1X10+6 mgL at 25 °C
蒸汽密度:
1.02 calculated (EPA, 1998) (Relative to Air)
蒸汽压力:
1.97 mm Hg at 25 °C
稳定性/保质期:
Stable under recommended storage conditions. /Hydrogen peroxide solution (>/= 30% to <50%)/
自燃温度:
Not flammable. (USCG, 1999)
分解:
Decomposition continuously occurs even at a slow rate when the compound is inhibited, and thus it must be stored properly and in vented containers. High-strength hydrogen peroxide is a very high-energy material. When it decomposes to oxygen and water, large amounts of heat are liberated, leading to an increased rate of decomposition, since decomposition is accelerated by increases in temperature. This rate increases about 2.2 times per 10 °C temperature increase between 20 and 100 °C.
Hydrogen peroxide is reduced by glutathione peroxidase, which is an endogenous enzyme in human tissue. It is rapidly decomposed to oxygen and water when in contact with catalase, an enzyme found in blood and most tissues.
IDENTIFICATION AND USE: Hydrogen peroxide is a colorless liquid. It is an oxidizing agent which, in the presence of organic matter or if permitted to become alkaline, vigorously decomposes to oxygen and water. Hydrogen peroxide is used as a 6% solution for bleaching hair, and some disinfectant solutions for contact lenses contain a 3% hydrogen peroxide. Chlorine-free bleaches contain 6% hydrogen peroxide. Some newer fabric stain removers and bleaches contain 5% to 15% hydrogen peroxide. Industrial strengths of hydrogen peroxide are manufactured up to 90%. They are used mainly as bleaching and oxidizing agents. Solutions of 90% are used as rocket fuel. HUMAN STUDIES: The dissociation of hydrogen peroxide is a violent and exothermic reaction. Ingestion results in gastrointestinal irritation, the severity of which depends on the concentration of the solution. There is also a risk for a gas embolism. A number of deaths have been reported in the literature. In most cases the exposures were to concentrated solutions of 30% to 40%. Other reactions include vomiting (the vomitus may be frothy due to the liberation of oxygen), hematemesis, burning of the throat, and gastric distension due to the release of oxygen. Lethargy, coma, convulsions, shock and respiratory arrest have also been reported. Gastrointestinal bleeding and burns to the stomach and duodenum may occur. In severe cases ischemic ECG changes and EMD (electromechanical dissociation) may be observed because of embolization of the heart restricting blood flow. Hydrogen peroxide is an irritant to the skin with paraesthesia, blistering and whitening; solutions >10% may cause burns. Hydrogen peroxide is irritating to the eyes with a burning sensation, conjunctival hyperemia, lacrimation, and severe pain which resolves within a few hours. There are rare cases of temporary corneal injury resulting from the application of 3% solution to the eye on contact lenses including punctuate staining of the cornea, decreased vision, corneal opacity and edema. Cerebral infarction resulting from gas embolization of the cerebral vasculature has been reported in an 84-year-old man. Multiple brain embolisms occurred in a 63-year-old who ingested hydrogen peroxide. DNA strand breaks and chromosomal aberrations were studied in human cells treated with hydrogen peroxide. DNA strand breaks could be produced at dose levels of hydrogen peroxide much lower than those which induced chromosomal aberrations. ANIMAL STUDIES: After ip injection of 0.5 mL of 5% hydrogen peroxide into adult mice, a radiation-like effect was observed; pyknotic nuclei were induced in the intestine and thymus within 2 hr and persisted for up to 24 hr. In rabbits and cats that died after iv administration of hydrogen peroxide, the lungs were found to be pale and emphysematous, with considerable amounts of gas in the great veins and in the right side of the heart. Application of a drop of 10 to 30% to rabbit's eye caused superficial corneal haze, and, if there were defects in the epithelium, could cause localized swelling and opacities in the corneal stroma. Also, 5% solution caused superficial corneal haze and much conjunctival reaction, but these effects were gone in 24 hr. Hydrogen peroxide was mutagenic to Salmonella typhimurium TA92 and TA102 and was positive in a forward mutation test in Salmonella typhimurium SV50. Single strand scissions were produced in T7 DNA upon incubation with hydrogen peroxide in aqueous solution at neutral pH. ECOTOXICITY STUDIES: Hydrogen peroxide was not teratogenic in Xenopus developing embryos.
Evaluation: There is inadequate evidence in humans for the carcinogenicity of hydrogen peroxide. There is limited evidence in experimental animals for the carcinogenicity of hydrogen peroxide. Overall evaluation: Hydrogen peroxide is not classifiable as to its carcinogenicity to humans (Group 3).
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌性证据
3A. 对动物已确认的致癌物,对人类的相关性未知。
A3. Confirmed animal carcinogen with unknown relevance to humans.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌物分类
国际癌症研究机构致癌物:过氧化氢
IARC Carcinogenic Agent:Hydrogen peroxide
来源:International Agency for Research on Cancer (IARC)
毒理性
致癌物分类
国际癌症研究机构(IARC)致癌物分类:第3组:对其对人类的致癌性无法分类
IARC Carcinogenic Classes:Group 3: Not classifiable as to its carcinogenicity to humans
来源:International Agency for Research on Cancer (IARC)
吸收、分配和排泄
吸收
据报道,过氧化氢在吸收进入小肠前就已经分解了。涂抹在组织上的过氧化氢溶液渗透性较差。
It is reported that hydrogen peroxide is decomposed before absorption in the intestine. Solutions of hydrogen peroxide displays poor penetration when applied to tissue.
来源:DrugBank
吸收、分配和排泄
分布容积
过氧化氢影响的靶器官包括肺、肠、胸腺、肝和肾。
Target organs affected by hydrogen peroxide include the lungs, intestine, thymus, liver, and kidney.
This in vivo study determined the kinetics of 3% hydrogen peroxide in a bleaching gel within the first hour. The material used in this study was 3% hydrogen peroxide gel and the study involved 10 subjects who met the inclusion and exclusion criteria. Each subject wore the tray with gel six different times on separate days. Evaluation of the remaining amount of hydrogen peroxide was calculated by the method stated in US Pharmacopoeia. The study results indicate that the mean percentage of hydrogen peroxide recovered for 5, 10, 20, 30, 45 and 60 minutes was 61, 56, 49, 44, 38 and 32, respectively. The amount of hydrogen peroxide in the saliva sample after one hour was 0.42 mg. Excluding the first 10 minutes, the kinetics of hydrogen peroxide in the tray and teeth sample was exponential.
Kappa 阿片受体 (KOR) 激动剂代表了有前途的缓解疼痛的疗法,因为它们具有镇痛特性,并且比作用于 mu 阿片受体的阿片类药物滥用可能性更低。然而,典型的 KOR 激动剂会产生镇静和烦躁。先前的研究表明,G 蛋白信号偏倚的 KOR 激动剂可能提供了一种将所需的镇痛特性与不需要的副作用分开的方法。在本文中,我们报道了一系列新的 G 蛋白信号偏倚的 KOR 激动剂,这些激动剂需要 –S– → –CH2– 替代先前报道的 KOR 激动剂三唑 1.1。有了优化的碳连接剂,对支架进行了进一步的开发,以研究三唑核心的附属物。描述了该系列的结构-活性关系研究,包括几种类似物,与三唑 1.1 相比,它们在保持 G 蛋白信号转导偏差的同时显示出增强的效力。
Novel mercapto-acylamino acids useful in the treatment of hypertension and combinations of mercapto-acylamino acids and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating hypertension are disclosed.
[EN] TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS TRICYCLIQUES INHIBITEURS DE PI3K ET PROCÉDÉS D'UTILISATION
申请人:HOFFMANN LA ROCHE
公开号:WO2012082997A1
公开(公告)日:2012-06-21
Tricyclic PI3k inhibitor compounds of Formula I with anti-cancer activity, anti- inflammatory activity, or immunoregulatory properties, and more specifically with PI3 kinase modulating or inhibitory activity are described. Methods are described for using the tricyclic PI3K inhibitor compounds of Formula I for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, organisms, or associated pathological conditions. Formula I compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. The dashed lines indicate an optional double bond, and at least one dashed line is a double bond. The substituents are as described.
harmful ROS, hydrogen peroxide, which can be depleted through peroxidaseactivity. The present work describes the synthesis of a hybrid, which unifies a superoxide dismutase mimetic, MnIIpyane, and a glutathioneperoxidase mimetic, ebselen, that are connected via an amide bond. This unique hybrid is designed in order to convert superoxide into oxygen and water, i.e. as a potential biological agent for
Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists
申请人:Merck & Co., Inc.
公开号:US05264439A1
公开(公告)日:1993-11-23
Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists. ##STR1##
通过一个亚甲基桥连接到新的取代苯基衍生物的取代杂环对式I的化合物可作为血管紧张素II拮抗剂。
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
申请人:Merck & Co., Inc.
公开号:US05401745A1
公开(公告)日:1995-03-28
Phenoxyphenylacetic acids and derivatives of general structural formula I ##STR1## have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebal and cardiac ischemia, myocardial infarction, inflammatory diseases, Raynaud's disease, and endotoxic shock, and asthma.